---
title: "JADARD today conducted a block trade at a discount, with 2.3577 million shares traded and a transaction amount of 54.4645 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234191964.md"
description: "On April 2nd, JADARD had a block trade of 2.3577 million shares, with a transaction amount of 54.4645 million yuan, accounting for 22.47% of the total transaction amount for the day. The transaction price was 23.1 yuan, which is a discount of 12.03% compared to the market closing price of 26.26 yuan"
datetime: "2025-04-02T09:28:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234191964.md)
  - [en](https://longbridge.com/en/news/234191964.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234191964.md)
generator: "portal-rs"
---

# JADARD today conducted a block trade at a discount, with 2.3577 million shares traded and a transaction amount of 54.4645 million yuan

On April 2nd, JADARD executed a block trade of 2.3577 million shares, with a transaction amount of 54.4645 million yuan, accounting for 22.47% of the total transaction amount for the day. The transaction price was 23.1 yuan, representing a discount of 12.03% compared to the market closing price of 26.26 yuan

### Related Stocks

- [688252.CN](https://longbridge.com/en/quote/688252.CN.md)

## Related News & Research

- [Pi Network: Mainnet upgrades to Protocol 27 - 15 Sep 2026](https://longbridge.com/en/news/296658153.md)
- [B3 announces availability of sustainability-related financial information report for FY2025](https://longbridge.com/en/news/296539532.md)
- [Elon Musk gives a timeline for SpaceX’s first Starship catch attempt](https://longbridge.com/en/news/296516633.md)
- [11:00 ETUnderstanding Lymph System Support Supplements: PureHealth Research Highlights Natural Ingredients for Everyday Wellness](https://longbridge.com/en/news/296684348.md)
- [PMGC unit NorthStrive Biosciences files US patents for EL-22, EL-32 to curb microgravity muscle loss](https://longbridge.com/en/news/296624370.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**